S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
NASDAQ:HSCS

Heart Test Laboratories (HSCS) Stock Price, News & Analysis

$0.12
-0.01 (-7.91%)
(As of 02/28/2024 ET)
Today's Range
$0.12
$0.12
50-Day Range
$0.11
$0.18
52-Week Range
$0.11
$1.49
Volume
766,491 shs
Average Volume
3.32 million shs
Market Capitalization
$7.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HSCS stock logo

About Heart Test Laboratories Stock (NASDAQ:HSCS)

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

HSCS Stock Price History

HSCS Stock News Headlines

Best At-Home Blood Tests: A 2024 Guide
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
HeartSciences Expands its Scientific Advisory Board
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
See More Headlines
Receive HSCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/14/2023
Today
2/28/2024
Next Earnings (Estimated)
3/21/2024
Fiscal Year End
4/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:HSCS
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Net Income
$-6,350,000.00
Pretax Margin
-101,483.33%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.02 per share

Miscellaneous

Free Float
61,882,000
Market Cap
$7.40 million
Optionable
Not Optionable
Beta
3.64
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Andrew Simpson (Age 55)
    CEO, President & Chairman of the Board of Directors
    Comp: $264.14k
  • Ms. Danielle Watson (Age 42)
    CFO & Treasurer
    Comp: $188.75k
  • Mr. Mark T. Hilz (Age 65)
    COO, Secretary & Director
    Comp: $263.61k














HSCS Stock Analysis - Frequently Asked Questions

How have HSCS shares performed in 2024?

Heart Test Laboratories' stock was trading at $0.1710 on January 1st, 2024. Since then, HSCS stock has decreased by 31.9% and is now trading at $0.1164.
View the best growth stocks for 2024 here
.

Are investors shorting Heart Test Laboratories?

Heart Test Laboratories saw a decline in short interest in the month of February. As of February 15th, there was short interest totaling 285,900 shares, a decline of 61.8% from the January 31st total of 748,600 shares. Based on an average daily volume of 6,550,000 shares, the short-interest ratio is currently 0.0 days. Currently, 3.1% of the shares of the stock are short sold.
View Heart Test Laboratories' Short Interest
.

When is Heart Test Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 21st 2024.
View our HSCS earnings forecast
.

How were Heart Test Laboratories' earnings last quarter?

Heart Test Laboratories, Inc. (NASDAQ:HSCS) released its earnings results on Thursday, December, 14th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.12) by $0.04.

When did Heart Test Laboratories IPO?

(HSCS) raised $9 million in an initial public offering (IPO) on Wednesday, June 15th 2022. The company issued 1,800,000 shares at $4.50-$5.50 per share. The Benchmark Company served as the underwriter for the IPO.

Who are Heart Test Laboratories' major shareholders?

Heart Test Laboratories' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Virtu Financial LLC (0.40%) and Vanguard Group Inc. (0.28%).

How do I buy shares of Heart Test Laboratories?

Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HSCS) was last updated on 2/29/2024 by MarketBeat.com Staff